Skip to contents
Stuart R. Lipsitz, SCD
Biostatistician, Brigham and Women's Hospital
Professor of Medicine, Harvard Medical School

Brigham and Women's Hospital
Department of Medicine
General Medicine
75 Francis Street
Boston, MA 02115


Edit Profile


Research Narrative:

Stuart Lipsitz, ScD, is the head of Biostatistical Services at the Center for Surgery and Public Health (CSPH) at Brigham and Women's Hospital, a position he assumed in 2005.  He holds an appointment as Associate Professor of Biostatistics at Harvard School of Public Health and an appointment in the Division of General Internal Medicine at Brigham and Women's Hospital.                     

Dr. Lipsitz received his ScD degree at Harvard University, and completed Post-Doctoral Fellowships at Harvard School of Public Health and Dana-Farber Cancer Institute.  He has previously held faculty appointments at the Harvard School of Public Health, the Dana-Farber Cancer Institute, and the Medical University of South Carolina, and currently holds a faculty position with Harvard Medical School.  He serves on the Biostatistical Methods and Research Design (BMRD) Study Section, Center for Scientific Review, National Institutes of Health, and is an Associate Editor for the Journal of the American Statistical Association.

In addition to serving as the head of Biostatistical Services at CSPH, he has an active research agenda, with interests including cardiotoxicity from cancer clinical trials and extending this collaborative effort to AIDS studies, in which patients may develop cardiac problems from the AIDS virus and/or AIDS treatments.  Dr. Lipsitz has published over 150 original articles in peer-reviewed national journals on a wide variety of statistical methodology, including repeated measures studies, methods of analysis with missing data, survival analysis and clinical trials, complex sample survey data analysis, and methods of analysis with ordinal categorical responses.  Repeated measurement studies arise in all areas of Public Health, and the responses are often categorical, not continuous, which resulted in Lipsitz proposing the use of a modified GEE (generalized estimating equations) approach to estimating the regression parameters for repeated measures studies with missing data.    Dr. Lipsitz is also involved in work with generalized linear models with missing data, and in survival analysis and clinical trials, developing new techniques for analyzing clustered survival data with missing data.


Education:
Harvard University, 1988, SCD

Publications (Pulled from Harvard Catalyst Profiles):

1. McCarty JC, Hashmi ZG, Herrera-Escobar JP, de Jager E, Chaudhary MA, Lipsitz SR, Jarman M, Caterson EJ, Goralnick E. Effectiveness of the American College of Surgeons Bleeding Control Basic Training Among Laypeople Applying Different Tourniquet Types: A Randomized Clinical Trial. JAMA Surg. 2019 Jul 24.

2. Schnock KO, Snyder JE, Fuller TE, Duckworth M, Grant M, Yoon C, Lipsitz S, Dalal AK, Bates DW, Dykes PC. Acute Care Patient Portal Intervention: Portal Use and Patient Activation. J Med Internet Res. 2019 Jul 18; 21(7):e13336.

3. Lu P, McCarty JC, Fields AC, Lee KC, Lipsitz SR, Goldberg JE, Irani J, Bleday R, Melnitchouk N. Risk of appendiceal cancer in patients undergoing appendectomy for appendicitis in the era of increasing nonoperative management. J Surg Oncol. 2019 Sep; 120(3):452-459.

4. Chaudhary MA, Bhulani N, de Jager EC, Lipsitz S, Kwon NK, Sturgeon DJ, Trinh QD, Koehlmoos T, Haider AH, Schoenfeld AJ. Development and Validation of a Bedside Risk Assessment for Sustained Prescription Opioid Use After Surgery. JAMA Netw Open. 2019 Jul 03; 2(7):e196673.

5. Macarayan EK, Ratcliffe HL, Otupiri E, Hirschhorn LR, Miller K, Lipsitz SR, Gawande AA, Bitton A. Facility management associated with improved primary health care outcomes in Ghana. PLoS One. 2019; 14(7):e0218662.

6. Fletcher SA, von Landenberg N, Cole AP, Gild P, Choueiri TK, Lipsitz SR, Trinh QD, Kibel AS. Contemporary national trends in prostate cancer risk profile at diagnosis. Prostate Cancer Prostatic Dis. 2019 Jun 24.

7. Linero AR, Sinha D, Lipsitz SR. Semiparametric Mixed-Scale Models Using Shared Bayesian Forests. Biometrics. 2019 Jun 21.

8. Tan WS, Krimphove MJ, Cole AP, Marchese M, Berg S, Lipsitz SR, Löppenberg B, Nabi J, Abdollah F, Choueiri TK, Kibel AS, Sooriakumaran P, Trinh QD. Variation in Positive Surgical Margin Status After Radical Prostatectomy for pT2 Prostate Cancer. Clin Genitourin Cancer. 2019 Jun 19.

9. Krimphove MJ, Szymaniak J, Marchese M, Tully KH, D'Andrea D, Mossanen M, Lipsitz SR, Kilbridge K, Kibel AS, Kluth LA, Shariat SF, Trinh QD. Sex-specific Differences in the Quality of Treatment of Muscle-invasive Bladder Cancer Do Not Explain the Overall Survival Discrepancy. Eur Urol Focus. 2019 Jun 18.

10. Schwarz D, Kim JH, Ratcliffe H, Bell G, Awoonor-Williams JK, Nimako B, Otupiri E, Lipsitz S, Hirschhorn L, Bitton A. The status of Ghanaian community health workers' supervision and service delivery: descriptive analyses from the 2017 Performance Monitoring and Accountability 2020 survey. Gates Open Res. 2019; 3:1468.